sumatriptan has been researched along with Disease Exacerbation in 2 studies
Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dynamics of migraine pain intensity measured with the VAS 30 min, 1, 2, 6 and 24 h after the first dose of drug was a primary index of efficacy." | 2.74 | [Trimigren in stopping migraine attacks: an open prospective multicenter comparative study of rectal suppository and tablet forms of sumatriptan]. ( Azimova, IuE; Tabeeva, GR, 2009) |
| "In some cases photo- and/or phonophobia (hyperexcitability) were not experienced at all, despite severe pain and nausea." | 2.72 | The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan. ( Dahlöf, C; Linde, M; Mellberg, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azimova, IuE | 1 |
| Tabeeva, GR | 1 |
| Linde, M | 1 |
| Mellberg, A | 1 |
| Dahlöf, C | 1 |
2 trials available for sumatriptan and Disease Exacerbation
| Article | Year |
|---|---|
[Trimigren in stopping migraine attacks: an open prospective multicenter comparative study of rectal suppository and tablet forms of sumatriptan].
Topics: Administration, Oral; Administration, Rectal; Adult; Aged; Disease Progression; Dose-Response Relati | 2009 |
The natural course of migraine attacks. A prospective analysis of untreated attacks compared with attacks treated with a triptan.
Topics: Adult; Aged; Comorbidity; Cross-Over Studies; Disease Progression; Female; Humans; Hyperacusis; Inci | 2006 |